好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Singular Expletive Use Accompanying Expressive Dysphasia in Acute Embolic Stroke
Behavioral Neurology
P06 - (-)
075
BACKGROUND: Expressive dysphasia often results from a lesion to the left cerebral hemisphere, usually in the inferior frontal lobe or insula. Frequent expletive use may occur in peri-sylvian neurological conditions including frontotemporal dementia and left hemispheric stroke, but isolated exclusive use the "F word" expletive has not been well described as an acute stroke phenomenon.
DESIGN/METHODS: Case report from a tertiary medical center.
RESULTS: A 39-year-old woman with a history of hypertension underwent ascending aortic aneurysm and aortic valve repair, and on the third post-operative day she was noted to have marked expressive dysphasia. On the following day she improved, able to follow lateralized and crossed requests, but had mild anomia and dysfluency. She remarkably included the "F word" in nearly every sentence, including its use in all grammatical modalities (verb, adjective, noun), and superfluous addition of the "F word" to the repetition task. She used no other expletives and did not exhibit inappropriate behavior. Magnetic resonance imaging of the brain revealed scattered areas of punctate supra- and infratentorial diffusion-weighted hyperintensities, most notably in the left peri-sylvian region. Her dysphasia and expletive use resolved over the next day.
CONCLUSIONS: More so than other expletives, the "F word" may have strong limbic connections correlating to the emotional attributes of language. These are more right hemisphere mediated, suggesting preferential retrieval of this expletive as a compensatory mechanism for an acute left peri-sylvian lesion affecting language output. This phenomenon may be observed in the recovery phase from ischemic stroke featuring dysphasia.
Authors/Disclosures
Clotilde Hainline, MD (University of New Mexico)
PRESENTER 		Dr. Hainline has nothing to disclose.
Shouri Lahiri, MD (Cedars-Sinai Medical Center) Dr. Lahiri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Lahiri has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medicolegal consultations.. Dr. Lahiri has stock in Prometheus. The institution of Dr. Lahiri has received research support from National Institutes of Health. The institution of Dr. Lahiri has received research support from F. Widjaja Foundation.
Matthew S. Robbins, MD, FAAN (Weill Cornell Medicine) Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, 好色先生 that is relevant to AAN interests or activities.
Luke Whitmire, PhD (Brain Sentinel) No disclosure on file
Stephan A. Mayer, MD (Henry Ford Hospital) Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.